Benzonatate Dose Tolerance Study

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

Cough

Interventions

DRUG

Placebo

Placebo - single dose at start of each treatment period

DRUG

Benzonatate - 400 mg

Benzonatate - 400 mg single dose

DRUG

Benzonatate - 600 mg

Benzonatate - 600 mg single dose

Trial Locations (1)

Pfizer Investigational Site, New Haven